UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal

Annals of the rheumatic diseases, 2019-07, Vol.78 (7), p.947-956

2019

Volltextzugriff (PDF)

Persistence of Disease‐Associated Anti–Citrullinated Protein Antibody–Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission

Arthritis & rheumatology (Hoboken, N.J.), 2017-06, Vol.69 (6), p.1176-1186

2017

Volltextzugriff (PDF)

The microbiome in SLE pathogenesis

Nature reviews. Rheumatology, 2019-02, Vol.15 (2), p.72-74

Silverman, Gregg J

2019

Volltextzugriff (PDF)

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis

Arthritis research & therapy, 2018-02, Vol.20 (1), p.36-36, Article 36

2018

Volltextzugriff (PDF)

Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes

Arthritis & rheumatology (Hoboken, N.J.), 2012-10, Vol.64 (10), p.3388-3398

2012

Volltextzugriff (PDF)

Could Compensatory Autoantibody Production Affect Rheumatoid Arthritis Etiopathogenesis?

Arthritis & rheumatology (Hoboken, N.J.), 2021-05, Vol.73 (5), p.728-730

Silverman, Gregg J.

2021

Volltextzugriff (PDF)

Protective autoantibodies in the rheumatic diseases: lessons for therapy

Nature reviews. Rheumatology, 2013-05, Vol.9 (5), p.291-300

2013

Volltextzugriff (PDF)

The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever

Nature reviews. Rheumatology, 2024-03, Vol.20 (3), p.143-157

2024

Volltextzugriff (PDF)

Response to: ‘The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus’ by Zhang et al and the phylogeny of a candidate pathobiont in lupus nephritis

Annals of the rheumatic diseases, 2021-11, Vol.80 (11), p.e178-e178

2021

Volltextzugriff (PDF)

Understanding the roles of the microbiome in autoimmune rheumatic diseases

Rheumatology and immunology research, 2023-12, Vol.4 (4), p.177-187

2023

Volltextzugriff (PDF)

Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares

Annals of the rheumatic diseases, 2023-10, Vol.82 (10), p.1315-1327

2023

Volltextzugriff (PDF)

Regulatory natural autoantibodies to apoptotic cells: Pallbearers and protectors

Arthritis & rheumatology (Hoboken, N.J.), 2011-03, Vol.63 (3), p.597-602

Silverman, Gregg J.

2011

Volltextzugriff (PDF)

Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responses

Journal of rheumatology, 2014-05, Vol.41 (5), p.825-828

2014

Volltextzugriff (PDF)

Is Gut Microbial LPS a Potential Trigger of Juvenile Idiopathic Arthritis?

Journal of rheumatology, 2017-11, Vol.44 (11), p.1569-1571

2017

Volltextzugriff (PDF)

Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis

Journal of rheumatology, 2016-02, Vol.43 (2), p.273-281

2016

Volltextzugriff (PDF)

Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment

Arthritis & rheumatology (Hoboken, N.J.), 2011-12, Vol.63 (12), p.3681-3691

2011

Volltextzugriff (PDF)

Roles of B cells in rheumatoid arthritis

Arthritis research & therapy, 2003-01, Vol.5 Suppl 4 (Suppl 4), p.S1-S6

2003

Volltextzugriff (PDF)

Rethinking the red wolf disease: does Protein S suppress systemic lupus erythematosus clinical activity?

Arthritis research & therapy, 2010-01, Vol.12 (5), p.144-144, Article 144

Silverman, Gregg J

2010

Volltextzugriff (PDF)

Co‐opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice

Arthritis & rheumatology (Hoboken, N.J.), 2011-12, Vol.63 (12), p.3897-3907

2011

Volltextzugriff (PDF)

Erratum to: Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis

Inflammation, 2015-08, Vol.38 (4), p.1580-1580

2015

Volltextzugriff (PDF)

Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O)

Journal of clinical rheumatology, 2015-08, Vol.21 (5), p.231-238

2015

Volltextzugriff (PDF)

Rituximab therapy and autoimmune disorders: Prospects for anti–B cell therapy

Arthritis and rheumatism, 2003-06, Vol.48 (6), p.1484-1492

2003

Volltextzugriff (PDF)

Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis

Inflammation, 2015-08, Vol.38 (4), p.1573-1579

2015

Volltextzugriff (PDF)

Therapeutic B cell depletion and regeneration in rheumatoid arthritis: Emerging patterns and paradigms

Arthritis and rheumatism, 2006-08, Vol.54 (8), p.2356-2367

Silverman, Gregg J.

2006

Volltextzugriff (PDF)

Anti‐CD20 therapy in systemic lupus erythematosus: A step closer to the clinic

Arthritis and rheumatism, 2005-02, Vol.52 (2), p.371-377

Silverman, Gregg J.

2005

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaRheumatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(20)
Autoantibodies
(10)
Animals
(9)
Female
(8)
Arthritis, Rheumatoid - Immunology
(7)
Lupus
(7)
B-Lymphocytes - Immunology
(6)
Biological And Medical Sciences
(6)
Diseases Of The Osteoarticular System
(6)
Male
(6)
Medical Sciences
(6)
Mice
(6)
Systemic Lupus Erythematosus
(6)
Adult
(5)
Arthritis, Rheumatoid - Drug Therapy
(5)
Autoantibodies - Immunology
(5)
Autoimmune Diseases
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal

Persistence of Disease‐Associated Anti–Citrullinated Protein Antibody–Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission

The microbiome in SLE pathogenesis

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis

Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes

Could Compensatory Autoantibody Production Affect Rheumatoid Arthritis Etiopathogenesis?

Protective autoantibodies in the rheumatic diseases: lessons for therapy

The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever

Response to: ‘The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus’ by Zhang et al and the phylogeny of a candidate pathobiont in lupus nephritis

Understanding the roles of the microbiome in autoimmune rheumatic diseases

Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares

Regulatory natural autoantibodies to apoptotic cells: Pallbearers and protectors

Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responses

Is Gut Microbial LPS a Potential Trigger of Juvenile Idiopathic Arthritis?

Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis

Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment

Roles of B cells in rheumatoid arthritis

Rethinking the red wolf disease: does Protein S suppress systemic lupus erythematosus clinical activity?

Co‐opting endogenous immunoglobulin for the regulation of inflammation and osteoclastogenesis in humans and mice

Erratum to: Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis

Efficacy and Safety of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, in a Heterogeneous Rheumatoid Arthritis Population: Results From a Randomized, Placebo-Controlled, Phase 3 Trial (FLEX-O)

Rituximab therapy and autoimmune disorders: Prospects for anti–B cell therapy

Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis

Therapeutic B cell depletion and regeneration in rheumatoid arthritis: Emerging patterns and paradigms

Anti‐CD20 therapy in systemic lupus erythematosus: A step closer to the clinic

Aktive Filter

Suchergebnisse filtern